HomeCTOR • NASDAQ
Citius Oncology Inc
add
$5.29
1.34%
After Hours:(1.32%)-0.070
$5.22
Closed: Jul 3, 4:51:53 PM UTC-4 · USD · NASDAQ · Disclaimer
Market news
.INX
0.83%
Financials
Income Statement
Revenue
Net Income
Revenue
Net income
(USD) | Mar 2025info | Y/Y change |
---|---|---|
Revenue | — | — |
Operating expense | 7.47M | 59.25% |
Net income | -7.74M | -59.97% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | — | — |
Effective tax rate | -3.54% | — |
Balance Sheet
Total Assets
Total Liabilities
Total assets
Total liabilities
(USD) | Mar 2025info | Y/Y change |
---|---|---|
Cash and short-term investments | 112.00 | — |
Total assets | 91.44M | 86.97% |
Total liabilities | 55.80M | 92.00% |
Total equity | 35.64M | — |
Shares outstanding | 71.55M | — |
Price to book | 10.44 | — |
Return on assets | -20.53% | — |
Return on capital | -44.19% | — |
Cash Flow
Net Change in Cash
Net change in cash
(USD) | Mar 2025info | Y/Y change |
---|---|---|
Net income | -7.74M | -59.97% |
Cash from operations | 0.00 | — |
Cash from investing | — | — |
Cash from financing | — | — |
Net change in cash | — | — |
Free cash flow | 2.80M | 59.25% |
Previous close
$5.22
Day range
$4.90 - $5.89
Year range
$0.55 - $49.00
Market cap
378.51M USD
Avg Volume
2.20M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
About
Founded
2021
Website